Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127235023 | 12723502 | 3 | F | 2010 | 20160913 | 20160908 | 20160920 | EXP | US-PFIZER INC-2016421046 | PFIZER | 55.00 | YR | F | Y | 95.25000 | KG | 20160920 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127235023 | 12723502 | 1 | PS | XANAX | ALPRAZOLAM | 1 | Oral | 0.25 MG, UNK | 18276 | .25 | MG | TABLET | |||||||
| 127235023 | 12723502 | 2 | SS | XANAX | ALPRAZOLAM | 1 | Oral | 0.25MG, ONE AND A HALF TABLET AT BED TIME | 18276 | .375 | MG | TABLET | QD | ||||||
| 127235023 | 12723502 | 3 | SS | XANAX | ALPRAZOLAM | 1 | 0.25 UNK | N08641 | 18276 | .25 | MG | TABLET | |||||||
| 127235023 | 12723502 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 40 MG, 1X/DAY (ONE IN THE MORNING) | 0 | 40 | MG | CAPSULE | QD | |||||||
| 127235023 | 12723502 | 5 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 10 MG, 1X/DAY (ONE IN THE MORNING) | 0 | 10 | MG | TABLET | QD | |||||||
| 127235023 | 12723502 | 6 | C | NASACORT AQ | TRIAMCINOLONE ACETONIDE | 1 | Nasal | 1 DF, AS NEEDED (ONE PUFF, EACH NOSTRIL) | 0 | 1 | DF | NASAL SPRAY |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127235023 | 12723502 | 1 | Anxiety |
| 127235023 | 12723502 | 4 | Gastrooesophageal reflux disease |
| 127235023 | 12723502 | 5 | Asthma |
| 127235023 | 12723502 | 6 | Hypersensitivity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127235023 | 12723502 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127235023 | 12723502 | Anaesthesia | |
| 127235023 | 12723502 | Anxiety | |
| 127235023 | 12723502 | Chest discomfort | |
| 127235023 | 12723502 | Condition aggravated | |
| 127235023 | 12723502 | Dizziness | |
| 127235023 | 12723502 | Drug dependence | |
| 127235023 | 12723502 | Drug ineffective | |
| 127235023 | 12723502 | Dyspnoea | |
| 127235023 | 12723502 | Gastrointestinal disorder | |
| 127235023 | 12723502 | Hyperhidrosis | |
| 127235023 | 12723502 | Loss of consciousness | |
| 127235023 | 12723502 | Product quality issue | |
| 127235023 | 12723502 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127235023 | 12723502 | 2 | 20160819 | 0 |